# BAVENCIO
> **BLA761078** · Biologics License Application · Sponsor: EMD SERONO INC · Approved 2017-05-09
## Drug
- **FDA Application Number:** BLA761078
- **Application type:** Biologics License Application
- **Brand name:** BAVENCIO
- **Generic name:** Avelumab
- **Active ingredients:** AVELUMAB
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** EMD SERONO INC
- **First approval:** 2017-05-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761078)
---
*MORVS · CC0 1.0*